Anacor Pharmaceuticals, Inc. Announces Pricing of Offering of $250 Million of 2.00% Convertible Senior Notes Due 2023

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today the pricing of its offering of $250,000,000 aggregate principal amount of 2.00% Convertible Senior Notes due 2023 (the “Convertible Notes”) in a private placement under the Securities Act of 1933, as amended (the “Securities Act”). Anacor also granted to the initial purchasers of the Convertible Notes a 30-day option to purchase up to an additional $37,500,000 aggregate principal amount of the Convertible Notes, solely to cover over-allotments, if any. The offering of the Convertible Notes is expected to close on April 6, 2016, subject to customary closing conditions.